Boonstra H, Duran V, Northington Gamble V, Blumenthal P, Dominguez L, Pies C
Reproductive Health Technologies Project, Washington, DC, USA.
Contraception. 2000 Jan;61(1):9-25. doi: 10.1016/s0010-7824(99)00121-3.
The "boom and bust phenomenon" is a pattern that has emerged in the development, introduction, and delivery of a number of significant new contraceptive products in the United States. When a new contraceptive product is introduced with great promise and publicity, it usually experiences a "boom" during which sales, demand, and expectations are high. This boom is often followed by a "bust" phase during which a product does not live up to expectations, initial excitement falls off, and a drop in sales and use ensues. The boom and bust phenomenon goes to the heart of what some have referred to as the failed promise of the contraception revolution by creating obstacles to significant expansion of contraceptive choice in the United States. Case studies of oral contraceptives, intrauterine devices, and Norplant(R) are used to illustrate the boom and bust phenomenon and the effect it has had in shaping the direction of advances in contraceptive technology.
“繁荣与萧条现象”是在美国许多重要新型避孕产品的研发、引入和推广过程中出现的一种模式。当一种新的避孕产品带着巨大的希望和宣传被推出时，它通常会经历一个“繁荣”阶段，在此期间销售、需求和期望都很高。这种繁荣之后往往会进入一个“萧条”阶段，在此期间产品无法达到预期，最初的兴奋感消退，随之而来的是销售和使用量的下降。繁荣与萧条现象触及了一些人所说的避孕革命未兑现承诺的核心，因为它为美国避孕选择的大幅扩展制造了障碍。口服避孕药、宫内节育器和诺普兰（Norplant）的案例研究被用来阐释繁荣与萧条现象及其在塑造避孕技术进步方向方面所产生的影响。
